baylishillman
adductderiv
ncinnamylsubstitut
isatin
deriv
synthes
evalu
antitubercular
activ
mycobacterium
tuberculosi
h
rv
strain
atcc
agar
dilut
method
anticanc
activ
compound
also
screen
four
differ
cell
line
chines
hamster
ovari
cho
cell
colo
human
colon
cancer
human
lymphoma
glioma
rat
glioma
mtt
assay
method
compound
shown
signific
activ
mycobacterium
strain
compound
shown
specif
cytotox
activ
isatin
privileg
natur
product
found
variou
plant
includ
genu
isati
guo
chen
also
found
human
metabol
deriv
adrenalin
ischia
et
al
synthet
flexibl
isatin
led
synthesi
array
substitut
deriv
display
broad
spectrum
biolog
properti
deriv
develop
therapeut
applic
variou
biolog
properti
isatin
includ
antibacterialantifung
varma
nobl
antivir
varma
nobl
anticanc
mates
et
al
antihiv
antitubercular
sriram
et
al
antiprotozo
raj
et
al
imam
antihelminth
elsawi
et
al
biolog
activ
silva
et
al
pandeya
et
al
hand
substitut
isatin
deriv
report
possess
dna
gyras
inhibitor
oblack
et
al
human
rhinoviru
proteas
inhibitor
webber
et
al
sar
corona
viru
proteas
inhibitor
zhou
et
al
inhibitor
activ
chu
et
al
investig
structureact
relationship
isatin
deriv
reveal
sriram
et
al
nalkyl
isatin
chen
et
al
singh
et
al
deriv
prove
show
mark
rise
biolog
activ
exampl
compound
approv
fda
treatment
gastrointestin
stromal
tumour
advanc
renal
cell
carcinoma
prenen
et
al
motzer
et
al
inspir
biolog
profil
isatin
increas
import
pharmaceut
biolog
field
connect
research
design
synthesi
biolog
activ
pharmacolog
import
new
heterocycl
narend
et
al
ravind
et
al
ravind
et
al
thought
worthwhil
synthes
titl
compound
view
obtain
certain
new
chemic
entiti
order
prepar
molecul
potenti
enhanc
biolog
activ
evalu
bioactiv
herein
report
synthesi
baylishillman
adductderiv
ncinnamylsubstitut
isatin
deriv
screen
antitubercular
anticanc
activ
start
substrat
deriv
obtain
commerci
wherea
baylishillman
bromid
prepar
treat
baylishillman
adduct
basavaiah
et
al
sing
batra
conc
h
aq
hbr
dcm
solvent
buchholz
hoffmann
optim
studi
focus
effort
search
suitabl
reaction
condit
prepar
target
compound
initi
reaction
carri
baylishillman
bromid
isatin
use
differ
base
nah
koh
k
co
net
naom
variou
solvent
dmf
acetonitril
meoh
scheme
studi
observ
k
co
acetonitril
suitabl
promot
complet
reaction
product
obtain
good
yield
mechanist
view
nucleophil
attack
allyl
bromid
baylishillman
adduct
two
fashion
n
n
lead
format
two
product
ii
shown
scheme
literatur
also
reveal
format
two
type
product
treat
baylishillman
bromid
buchholz
hoffmann
nucleophil
studi
reaction
n
product
obtain
exclus
rather
n
type
product
reason
bulki
isatin
nucleophil
fail
attack
bposit
baylishillman
bromid
n
path
due
steric
repuls
gain
aromat
group
henc
attack
stericfre
allyl
carbon
bromid
group
via
n
path
lead
compound
exclus
confirm
spectral
analysi
seri
compound
synthes
optim
condit
good
yield
product
synthes
well
character
spectroscop
techniqu
thu
synthes
product
screen
anticanc
activ
four
differ
cell
line
mtt
assay
method
antituberculosi
activ
mycobacterium
tuberculosi
h
rv
strain
atcc
agar
dilut
method
synthes
compound
screen
vitro
antitubercular
activ
mtb
tuberculosi
h
rv
strain
atcc
agar
dilut
method
determin
mic
duplic
minimum
inhibitori
concentr
mic
lgml
determin
compound
mic
defin
minimum
concentr
compound
requir
complet
inhibit
bacteri
growth
rifampicin
isoniazid
ethambutol
pyrazinamid
use
refer
drug
result
vitro
antitubercular
activ
mic
lgml
along
standard
drug
comparison
summar
tabl
screen
compound
shown
moder
good
vitro
activ
tuberculosi
mic
rang
scheme
synthesi
ncinnamylsubstitut
isatin
deriv
med
chem
re
re
re
re
lgml
compound
potent
pyrazinamid
drug
lgml
less
potent
rifampicin
lgml
compound
show
better
activ
ethambutol
lgml
result
clearli
indic
antitubercular
activ
synthes
compound
depend
substitu
present
moieti
isatin
cinnamyl
compound
substitu
moieti
well
compound
one
halo
substitu
either
isatin
cinnamyl
moieti
display
poor
activ
except
compound
nitro
group
phenyl
ring
compound
differ
halogen
substitu
moieti
show
moder
antitubercular
activ
except
compound
bromin
substitu
moieti
replac
halogen
group
phenyl
ring
cinnamyl
moieti
compound
nitro
group
enhanc
antitubercular
activ
lgml
close
standard
isoniazid
drug
lgml
vitro
result
antitubercular
activ
encourag
us
evalu
anticanc
effect
panel
four
cell
line
preliminari
cytotox
set
compound
screen
four
cell
line
compris
noncancer
chines
hamster
ovari
cell
cho
cancer
colo
human
colon
cancer
human
lymphoma
glioma
rat
glioma
cell
line
determin
mtt
assay
method
result
data
show
specif
cytotox
compound
cancer
cell
line
compound
found
toxic
cell
viabil
fig
c
toward
glioma
cell
howev
compound
found
equal
toxic
cancer
noncancer
cell
interestingli
compound
show
higher
cytotox
colon
cell
compar
glioma
fig
result
suggest
compound
seri
compound
activ
cancer
cell
glioma
particular
comprehens
activ
studi
need
carri
establish
anticanc
activ
compound
chemic
research
grade
use
asobtain
commerci
aldrich
reaction
carri
roundbottom
flask
ml
capac
room
temperatur
effici
fume
hood
progress
reaction
monitor
tlc
use
tlc
aluminium
sheet
precoat
silica
gel
f
thick
mm
merck
flash
column
chromatographi
done
use
silica
gel
merck
mesh
melt
point
determin
meltemp
ii
melt
point
apparatu
uncorrect
ir
spectra
record
perkinelm
ftir
spectrophotomet
h
c
nmr
spectra
record
varian
gemini
mhz
bruker
avanc
mhz
spectromet
tm
use
intern
standard
cdcl
dmsod
mass
spectra
record
vg
micro
mass
h
ei
qstar
xl
high
resolut
mass
spectromet
hrm
thermofinnigan
esi
ion
trap
mass
spectromet
gener
experiment
procedur
prepar
ncinnamylsubstitut
isatin
deriv
solut
isatin
mg
mmol
acetonitril
ml
k
co
mg
mmol
ad
follow
baylishillman
bromid
mg
mmol
room
temperatur
reaction
mixtur
stir
h
upon
complet
reaction
mixtur
filter
filtrat
dilut
water
ml
scheme
nucleophil
substitut
baylishillman
bromid
extract
etoac
ml
combin
organ
layer
dri
na
filter
concentr
reduc
pressur
obtain
crude
product
purifi
silica
gel
column
chromatographi
mesh
eluent
etoachexan
afford
pure
cinnamylsubstitut
isatin
deriv
solid
compound
methyl
ms
cytotox
assay
procedur
potenti
effect
cell
viabil
investig
use
mtt
assay
sigma
usa
bromid
indic
metabol
activ
cell
van
de
loosdrecht
et
al
alley
et
al
four
differ
cell
line
use
cho
colo
glioma
seed
plate
volum
ml
cultur
medium
incub
overnight
co
incub
addit
test
compound
cell
expos
known
concentr
compound
test
mm
lm
nm
pm
express
final
concentr
h
co
incub
co
drug
exposur
cultur
medium
remov
mtt
reagent
dilut
cultur
medium
mgml
ad
incub
h
humidifi
atmospher
mttmedium
remov
dmso
ad
dissolv
formazan
crystal
absorb
colour
solut
measur
elisa
use
micropl
spectrophotomet
test
wavelength
nm
result
evalu
compar
absorb
well
contain
compoundtr
cell
absorb
well
contain
dmso
alon
solvent
control
convent
cell
viabil
estim
solvent
control
assay
perform
triplic
mean
standard
deviat
valu
use
estim
cell
viabil
conclus
seri
new
baylishillman
adductderiv
ncinnamylsubstitut
isatin
deriv
synthes
simpl
effici
manner
synthes
compound
evalu
antitubercular
anticanc
activ
compound
inhibit
mycobacterium
strain
especi
compound
shown
overal
good
activ
tuberculosi
h
rv
strain
atcc
compound
show
specif
cytotox
cancer
cell
line
colo
wherea
noncytotox
noncancer
cell
line
cho
